Minimally invasive spine company uses Fitbit to track patients' improvements: 3 notes

Written by Mackenzie Garrity | February 06, 2019 | Print  |

Minimally invasive spine device developer Vertos Medical is using Fitbits in a trial to measure improvements in mobility and opioid use following surgery, according to WNDU, an NBC affiliate.

Three notes:

1. After undergoing the minimally invasive Mild procedure, physicians will track patient's success through the Fitbit.

2. The motion study is being conducted at 20 centers. Patients will be evaluated at six-, 12- and 24-months postoperatively.

3. Vertos Medical expects to have the results of the randomized, controlled study in a year and a half.

More articles on devices and implants:
3 things to know about Group FH Ortho
Nanovis wins Global Health & Pharma's nanotechnology award: 3 details
Minimally invasive surgical instruments market to reach $38.3B by 2025 due to spine surgery demands

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months